R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Price:
0.68
MYR
Market Closed
Market Cap:
152.5m
MYR
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
MY |
|
20 Microns Ltd
NSE:20MICRONS
|
IN |
|
United Therapeutics Corp
NASDAQ:UTHR
|
US |
|
C
|
Chakana Copper Corp
SWB:1ZX
|
CA |
|
Orbit Exports Ltd
NSE:ORBTEXP
|
IN |
|
M
|
Magnum Ventures Ltd
NSE:MAGNUM
|
IN |
|
Danske Andelskassers Bank A/S
CSE:DAB
|
DK |
|
1
|
123fahrschule SE
F:123F
|
DE |
|
U
|
Uniinfo Telecom Services Ltd
NSE:UNIINFO
|
IN |
|
E
|
Elpro International Ltd
BSE:504000
|
IN |
|
AerSale Corp
NASDAQ:ASLE
|
US |
|
P
|
Pil Italica Lifestyle Ltd
NSE:PILITA
|
IN |
Multiples-Based Value
The Multiples-Based Value of one RHONEMA stock under the Base Case scenario is hidden MYR. Compared to the current market price of 0.68 MYR, Rhone Ma Holdings Bhd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RHONEMA Multiples-Based Value
LOCKED
Multiples Across Competitors
RHONEMA Competitors Multiples
Rhone Ma Holdings Bhd Competitors
Rhone Ma Holdings Bhd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| MY |
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
149.7m MYR | 0.7 | 10.6 | 4.4 | 5.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
